Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1
Abstract
Mice with liver-specific overexpression of dominant negative phosphorylation-defective S503A-CEACAM1 mutant (L-SACC1) developed chronic hyperinsulinemia resulting from blunted hepatic clearance of insulin, visceral obesity, and glucose intolerance. To determine the underlying mechanism of altered glucose homeostasis, a 2-h hyperinsulinemic euglycemic clamp was performed, and tissue-specific glucose and lipid metabolism was assessed in awake L-SACC1 and wild-type mice. Inactivation of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) caused insulin resistance in liver that was mostly due to increased expression of fatty acid synthase and lipid metabolism, resulting in elevated intrahepatic levels of triglyceride and long-chain acyl-CoAs. Whole body insulin resistance in the L-SACC1 mice was further attributed to defects in insulin-stimulated glucose uptake in skeletal muscle and adipose tissue. Insulin resistance in peripheral tissues was associated with significantly elevated intramuscular fat contents that may be secondary to increased whole body adiposity (assessed by (1)H-MRS) in the L-SACC1 mice. Overall, these results demonstrate that L-SACC1 is a mouse model in which chronic hyperinsulinemia acts as a cause, and not a consequence, of insulin resistance. Our findings further indicate the important role of CEACAM1 and hepatic insulin clearance in the pathogenesis of obesity and insulin resistance.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Fatty acid-induced reductions in insulin receptor number and function in the liver may also reduce hepatic insulin clearance, causing systemic hyperinsulinemia, itself a contributor to both insulin resistance and reduced mitochondrial function.
“Fatty acid-induced reductions in insulin receptor number and function in the liver (211) may also reduce hepatic insulin clearance (226), causing systemic hyperinsulinemia, itself a contributor to both insulin resistance and reduced mitochondrial function (214,227,228).”
From The role of mitochondria in the pathogenesis of type 2 diabetes (2010) · cites this paper as [227]
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518 · see citing works
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915 · see citing works
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755 · see citing works
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714 · see citing works
Self-citationThe Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456 · see citing works
Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884 · see citing works
Kern, P. A., Ranganathan, S., Li, C., Wood, L., & Ranganathan, G. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e745 · Cited by 1,883 · see citing works
Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561 · see citing works
Self-citationBoden, G., & Shulman, G. I. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.32.s3.3.x · Cited by 1,300 · see citing works
Griffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., Goodyear, L. J., Kraegen, E. W., White, M. F., & Shulman, G. I. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1270 · Cited by 1,267 · see citing works
Self-citationKrssak, M., Falk Petersen, K., Dresner, A., DiPietro, L., Vogel, S. M., Rothman, D. L., Shulman, G. I., & Roden, M. (1999) · Diabetologia · doi:10.1007/s001250051123 · Cited by 1,264 · see citing works
Self-citationLipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis
Goldberg, I. J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37569-6 · Cited by 1,009 · see citing works
Insulin Action, Diabetogenes, and the Cause of Type II Diabetes
Kahn, C. R. (1994) · Diabetes · doi:10.2337/diab.43.8.1066 · Cited by 916 · see citing works
The Obesity Epidemic: Pathophysiology and Consequences of Obesity
Pi‐Sunyer, F. X. (2002) · Obesity Research · doi:10.1038/oby.2002.202 · Cited by 856 · see citing works
Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance
Kim, J. K., Fillmore, J. J., Chen, Y., Yu, C., Moore, I. K., Pypaert, M., Lutz, E. P., Kako, Y., Velez-Carrasco, W., Goldberg, I. J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121164498 · Cited by 753 · see citing works
What if Minkowski Had Been Ageusic? An Alternative Angle on Diabetes
McGarry, J. D. (1992) · Science · doi:10.1126/science.1439783 · Cited by 657 · see citing works
Development of Muscle Insulin Resistance After Liver Insulin Resistance in High-Fat–Fed Rats
Kraegen, E. W., Clark, P. W., Jenkins, A. B., Daley, E. A., Chisholm, D. J., & Storlien, L. H. (1991) · Diabetes · doi:10.2337/diab.40.11.1397 · Cited by 601 · cited 1× · see citing works
“Inverse relationship between intracellular fat content and insulin sensitivity has been well documented in studies involving both humans and animal models (23, 22, 38).”
BackgroundRui, L., Aguirre, V., Kim, J. K., Shulman, G. I., Lee, A., Corbould, A. M., Dunaif, A. E., & White, M. F. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10934 · Cited by 600 · see citing works
Differential Effects of Interleukin-6 and -10 on Skeletal Muscle and Liver Insulin Action In Vivo
Kim, H.-J., Higashimori, T., Park, S.-Y., Choi, H., Dong, J., Kim, Y.-J., Noh, H.-L., Cho, Y.-R., Cline, G., Kim, Y.-B., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.4.1060 · Cited by 534 · see citing works
Self-citationPKC-θ knockout mice are protected from fat-induced insulin resistance
Kim, J. K., Fillmore, J. J., Sunshine, M. J., Albrecht, B., Higashimori, T., Kim, D.-W., Liu, Z.-X., Soos, T. J., Cline, G. W., O’Brien, W. R., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422230 · Cited by 500 · see citing works
Self-citationFree fatty acids and insulin resistance
Delarue, J., & Magnan, C. (2007) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328042ba90 · Cited by 463 · see citing works
Lipoapoptosis: its mechanism and its diseases
Unger, R. H., & Orci, L. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00342-6 · Cited by 361 · see citing works
Kim, J. K., Michael, M. D., Previs, S. F., Peroni, O. D., Mauvais-Jarvis, F., Neschen, S., Kahn, B. B., Kahn, C. R., & Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8305 · Cited by 331 · see citing works
Self-citationSerine/Threonine Phosphorylation of IRS-1 Triggers Its Degradation
Pederson, T. M., Kramer, D. L., & Rondinone, C. M. (2001) · Diabetes · doi:10.2337/diabetes.50.1.24 · Cited by 300 · see citing works
Hajri, T., Han, X. X., Bonen, A., & Abumrad, N. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14596 · Cited by 277 · see citing works
CEACAM1 regulates insulin clearance in liver
Poy, M. N., Yang, Y., Rezaei, K., Fernström, M. A., Lee, A. D., Kido, Y., Erickson, S. K., & Najjar, S. M. (2002) · Nature Genetics · doi:10.1038/ng840 · Cited by 269 · see citing works
Stahl, A., Evans, J. G., Pattel, S., Hirsch, D. B., & Lodish, H. F. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00143-0 · Cited by 259 · see citing works
Kim, J. K., Gimeno, R. E., Higashimori, T., Kim, H., Choi, H., Punreddy, S., Mozell, R. L., Tan, G., Stricker‐Krongrad, A., Hirsch, D. J., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18917 · Cited by 244 · see citing works
Hajri, T., Han, X. X., Bonen, A., & Abumrad, N. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214596 · Cited by 228 · see citing works
Koyama, K., Chen, G., Lee, Y., & Unger, R. H. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.4.e708 · Cited by 227 · see citing works
Kim, J. K., Gimeno, R. E., Higashimori, T., Kim, H., Choi, H., Punreddy, S., Mozell, R. L., Tan, G., Stricker‐Krongrad, A., Hirsch, D. J., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200418917 · Cited by 212 · see citing works
Unraveling the mechanism of action of thiazolidinediones
Kahn, C. R., Chen, L., & Cohen, S. E. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11705 · Cited by 191 · see citing works
Insulin acutely decreases hepatic fatty acid synthase activity
Najjar, S. M., Yang, Y., Fernström, M. A., Lee, S.-J., DeAngelis, A. M., Abou-Rjaily, G. A., Al–Share, Q. Y., Dai, T., Miller, T. A., Ratnam, S., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.06.001 · Cited by 116 · see citing works
Triglycerides, fatty acids and insulin resistance - hyperinsulinemia
Kraegen, E., Cooney, G., Ye, J., & Thompson, A. (2001) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2001-15114 · Cited by 114 · see citing works
Park, S., Kim, H., Wang, S., Higashimori, T., Dong, J., Kim, Y. J., Cline, G. W., Li, H., Prentki, M., Shulman, G. I., et al. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00251.2004 · Cited by 105 · see citing works
Najjar, S. M., Philippe, N., Suzuki, Y., Ignacio, G. A., Formisano, P., Accili, D., & Taylor, S. I. (1995) · Biochemistry · doi:10.1021/bi00029a009 · Cited by 90 · see citing works
Receptor-mediated Internalization of Insulin
Formisano, P., Najjar, S. M., Gross, C. N., Philippe, N., Oriente, F., Kern-Buell, C. L., Accili, D., & Görden, P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.24073 · Cited by 86 · see citing works
Type 2 diabetes worldwide according to the new classification and criteria.
Shaw, J. E., Zimmet, P. Z., McCarty, D., & de Courten, M. (2000) · PubMed · Cited by 83 · see citing works
Angiogenic Properties of the Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1
Wagener, C., & Ergün, S. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.5038 · Cited by 64 · see citing works
Sadekova, S., Lamarche‐Vane, N., Li, X., & Beauchemin, N. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.1.65 · Cited by 64 · see citing works
Insulin Stimulates pp120 Endocytosis in Cells Co-expressing Insulin Receptors
Choice, C. V., Howard, M. J., Poy, M. N., Hankin, M., & Najjar, S. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22194 · Cited by 46 · see citing works
Obesity, free fatty acids, and insulin resistance
Boden, G. H. (2001) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200110000-00002 · Cited by 46 · see citing works
Joshi, A. K., & Smith, S. (1993) · Biochemical Journal · doi:10.1042/bj2960143 · Cited by 45 · see citing works
Soni, P., Lakkis, M., Poy, M. N., Fernström, M. A., & Najjar, S. M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.3896-3905.2000 · Cited by 42 · see citing works
Interaction between Altered Insulin and Lipid Metabolism in CEACAM1-inactive Transgenic Mice
Dai, T., Abou-Rjaily, G. A., Al–Share, Q. Y., Yang, Y., Fernström, M. A., DeAngelis, A. M., Lee, A. D., Sweetman, L., Amato, A., Pasquali, M., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404764200 · Cited by 29 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The role of mitochondria in the pathogenesis of type 2 diabetes
Patti, M.-E., & Corvera, S. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0027 · Cited by 551 · see citing works
Non-Alcoholic Fatty Liver Disease and the Metabolic Syndrome
Najjar, S. M. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1607-5_12 · Cited by 354 · see citing works
Chokshi, A. D., Drosatos, K., Cheema, F. H., Ji, R., Khawaja, T., Yu, S., Kato, T., Khan, R. S., Takayama, H., Knöll, R., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.060889 · Cited by 297 · see citing works
Hepatic Insulin Clearance: Mechanism and Physiology
Najjar, S. M., & Perdomo, G. (2019) · Physiology · doi:10.1152/physiol.00048.2018 · Cited by 252 · see citing works
Muniyappa, R., Chen, H., Muzumdar, R. H., Einstein, F. H., Xu, Y., Yue, L. Q., Barzilai, N., & Quon, M. J. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00397.2009 · Cited by 179 · see citing works
Lee, S., Muniyappa, R., Xu, Y., Chen, H., Yue, L. Q., Hong, E., Kim, J. K., & Quon, M. J. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00676.2007 · Cited by 158 · see citing works
Gene expression profile of the bone microenvironment in human fragility fracture bone
Hopwood, B., Tsykin, A., Findlay, D. M., & Fazzalari, N. L. (2008) · Bone · doi:10.1016/j.bone.2008.08.120 · Cited by 114 · see citing works
Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1
DeAngelis, A. M., Heinrich, G., Dai, T., Bowman, T. A., Patel, P. R., Lee, S. J., Hong, E., Jung, D. Y., Aßmann, A., Kulkarni, R. N., et al. (2008) · Diabetes · doi:10.2337/db08-0379 · Cited by 105 · see citing works
Xu, J., Morinaga, H., Oh, D., Li, P., Chen, A., Talukdar, S., Lazarowski, E. R., Olefsky, J. M., & Kim, J. J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103207 · Cited by 84 · see citing works
TRPM2 Ca2+ channel regulates energy balance and glucose metabolism
Zhang, Z., Zhang, W., Jung, D. Y., Ko, H. J., Lee, Y., Friedline, R. H., Lee, E., Jun, J. Y., Ma, Z., Kim, F., et al. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00239.2011 · Cited by 76 · see citing works
Toda, C., Shiuchi, T., Kageyama, H., Okamoto, S., Coutinho, E. A., Sato, T., Okamatsu‐Ogura, Y., Yokota, S., Takagi, K., Tang, L., et al. (2013) · Diabetes · doi:10.2337/db12-1629 · Cited by 63 · see citing works
Huang, S., Kaw, M., Harris, M., Ebraheim, N. A., McInerney, M. F., Najjar, S. M., & Lecka‐Czernik, B. (2010) · Bone · doi:10.1016/j.bone.2009.12.020 · Cited by 63 · see citing works
Warrier, M., Hinds, T. D., Ledford, K. J., Cash, H. A., Patel, P. R., Bowman, T. A., Stechschulte, L. A., Yong, W., Shou, W., Najjar, S. M., et al. (2010) · Endocrinology · doi:10.1210/en.2009-1158 · Cited by 57 · see citing works
Korean Red Ginseng (Panax ginseng) Improves Insulin Sensitivity in High Fat Fed Sprague‐Dawley Rats
Lee, S. H., Lee, H. J., Lee, Y., Lee, B., Cha, B. S., Kang, E. S., Ahn, C. W., Park, J. S., Kim, H. J., Lee, E. Y., et al. (2011) · Phytotherapy Research · doi:10.1002/ptr.3610 · Cited by 55 · see citing works
Xu, E., Dubois, M.-J., Leung, N., Charbonneau, A., Turbide, C., Avramoglu, R. K., DeMarte, L., Elchebly, M., Streichert, T., Levy, E. H., et al. (2009) · Endocrinology · doi:10.1210/en.2008-1439 · Cited by 53 · see citing works
CEACAMS 1, 5, and 6 in disease and cancer: interactions with pathogens
Thomas, J., Klebanov, A., John, S., Miller, L. S., Vegesna, A. K., AMDUR, R. L., Bhowmick, K., & Mishra, L. (2023) · Genes & Cancer · doi:10.18632/genesandcancer.230 · Cited by 50 · see citing works
Bowman, T. A., Ramakrishnan, S. K., Kaw, M., Lee, S. J., Patel, P. R., Golla, V. K., Bourey, R. E., Haram, P. M., Koch, L. G., Britton, S. L., et al. (2010) · Endocrinology · doi:10.1210/en.2010-0176 · Cited by 44 · see citing works
Ramakrishnan, S. K., Khuder, S. S., Al–Share, Q. Y., Russo, L., Abdallah, S. L., Patel, P. R., Heinrich, G., Muturi, H. T., Mopidevi, B., Oyarce, A. M., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.714014 · Cited by 44 · see citing works
Heinrich, G., Ghadieh, H. E., Ghanem, S. S., Muturi, H. T., Rezaei, K., Al–Share, Q. Y., Bowman, T. A., Zhang, D., Garofalo, R. S., Yin, L., et al. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00008 · Cited by 42 · see citing works
Najjar, S. M., & Russo, L. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0407-3 · Cited by 40 · see citing works
Prevalence and Predictors of Insulin Resistance in Non-Obese Healthy Young Females in Qatar
Elrayess, M. A., Rizk, N. M., Fadel, A., & Kerkadi, A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17145088 · Cited by 31 · see citing works
Mice with null mutation of Ceacam1 develop nonalcoholic steatohepatitis
Najjar, S. M. (2010) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s8902 · Cited by 30 · see citing works
Convit, A. J., Wedin, W., & Diaz-Gimenez (2012) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s33478 · Cited by 24 · see citing works
Heinrich, G., Ghosh, S., DeAngelis, A. M., Schroeder, J. M., Patel, P. R., Castañeda, T. R., Jeffers, S., Lee, A. D., Jung, D. Y., Zhang, Z., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.056 · Cited by 24 · see citing works
Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis
Russo, L., Ghadieh, H. E., Ghanem, S. S., Al–Share, Q. Y., Smiley, Z. N., Gatto-Weis, C. M., Esakov, E. L., McInerney, M. F., Heinrich, G., Tong, X., et al. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m072066 · Cited by 22 · see citing works
Lester, S. G., Russo, L., Ghanem, S. S., Khuder, S. S., DeAngelis, A. M., Esakov, E. L., Bowman, T. A., Heinrich, G., Al–Share, Q. Y., McInerney, M. F., et al. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00116 · Cited by 19 · see citing works
Patel, P. R., Ramakrishnan, S. K., Kaw, M., Raphael, C. K., Ghosh, S., Marino, J. S., Heinrich, G., Lee, S. J., Bourey, R. E., Hill, J. W., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2388-x · Cited by 19 · see citing works
Reduced Hepatic Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Level in Obesity
Heinrich, G., Muturi, H. T., Rezaei, K., Al–Share, Q. Y., DeAngelis, A. M., Bowman, T. A., Ghadieh, H. E., Ghanem, S. S., Zhang, D., Garofalo, R. S., et al. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00054 · Cited by 19 · see citing works
de Rezende, L. F., Camargo, R. L., Branco, R. C. S., Cappelli, A. P. G., Boschero, A. C., & Carneiro, E. M. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114514001238 · Cited by 18 · see citing works
Ghanem, S. S., Muturi, H. T., DeAngelis, A. M., Hu, J., Kulkarni, R., Heinrich, G., & Najjar, S. M. (2017) · Diabetologia · doi:10.1007/s00125-017-4307-2 · Cited by 13 · see citing works
Wasserman, D. H., Ayala, J. E., & McGuinness, O. P. (2009) · Diabetes · doi:10.2337/db09-0537 · Cited by 9 · see citing works
Phosphorylation of human CEACAM1-LF by PKA and GSK3β promotes its interaction with β-catenin
Hu, W., Bagramyan, K. A., Bhatticharya, S., Hong, T., Tapia, A., Wong, P. W., Kalkum, M., & Shively, J. E. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101305 · Cited by 8 · see citing works
The Effect of Taurine Supplementation on Glucose Homeostasis: The Role of Insulin-Degrading Enzyme
Camargo, R. L., Branco, R. C. S., de Rezende, L. F., Vettorazzi, J. F., Borck, P. C., Boschero, A. C., & Carneiro, E. M. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-15126-7_57 · Cited by 8 · see citing works
Insulin increases type I collagen synthesis in hepatic stellate cells via α5β1 integrin
Dodig, M., Li, M., Dasarathy, S., Kumarasamy, S., Kasumov, T., Najjar, S. M., & McCullough, A. J. (2024) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2024.59 · Cited by 6 · see citing works
TRPM2 Function and Potential as a Drug Target
Miller, B. A. (2012) · Methods in pharmacology and toxicology · doi:10.1007/978-1-62703-077-9_5 · Cited by 6 · see citing works
Lu, S. X., Kappel, L. W., Charbonneau-Allard, A.-M., Atallah, R., Holland, A. M., Turbide, C., Hubbard, V. M., Rotolo, J. A., Smith, M. O., Suh, D. Y., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021611 · Cited by 5 · see citing works
Vogt, J. A., Domzig, C., Wabitsch, M., & Denzer, C. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00455.2014 · Cited by 3 · see citing works
Pathway‐Based Methods for Analyzing Microarray Data
Pang, H., Kim, I., & Zhao, H. (2008) · doi:10.1002/9783527622818.ch13 · Cited by 3 · see citing works
Weiskirchen, R. (2025) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2024.133 · Cited by 1 · see citing works
Harake, S. N. A., Abedin, Y., Hatoum, F., Nassar, N. Z., Ali, A., Nassar, A., Kanaan, A., Bazzi, S. I., Azar, S. T., Harb, F., et al. (2024) · Adipocyte · doi:10.1080/21623945.2024.2403380 · Cited by 1 · see citing works
The Lipogenic Effect of Insulin Revisited
Najjar, S. M. (2015) · Springer eBooks · doi:10.1007/978-3-319-25065-6_14 · Cited by 1 · see citing works
Bourey, R. E., Kaw, M., Lester, S. G., Ghanem, S. S., & Najjar, S. M. (2014) · CRC Press eBooks · doi:10.1201/b16783-4 · Cited by 1 · see citing works
La régulation du métabolisme du glucose par la protéine tyrosine phosphatase SHP-1
Bergeron, S. (2007) · Corpus Université Laval (Université Laval) · Cited by 1 · see citing works
Najjar, S. M., Bourey, R. E., Haram, P. M., Koch, L. G., Britton, S. L., Wisløff, U., Lee, A. D., Bowman, T. A., Ramakrishnan, S. K., Kaw, M., et al. (2010)
Hepatic CEACAM1 protects against metabolic abnormalities associated with metabolic syndrome.
Bowman, T. A. (2010) · OhioLink ETD Center (Ohio Library and Information Network)
A role for CEACAM2 in insulin homeostasis and action
Patel, P. R. (2010) · OhioLink ETD Center (Ohio Library and Information Network)
Loss of CEACAM1 in the Pathogenesis of Vascular Abnormalities Associated with the Metabolic Syndrome
Ledford, K. J. (2010) · OhioLink ETD Center (Ohio Library and Information Network)
Effects of Exercise Training on Metabolic Intermediate Phenotypes in Inbred Rat Strains
Ghosh, S. (2007) · OhioLink ETD Center (Ohio Library and Information Network)
Molecular mechanisms underlying the effects of CB1 antagonism in canine model of obesity
Iyer, M. S. (2015) · University of Southern California Digital Library · doi:10.25549/usctheses-m2706
Effects of Cardiotonic Steroids and Insulin on Sodium Pump Signaling
Gupta, S. (2014) · OhioLink ETD Center (Ohio Library and Information Network)
Xu, E. (2012) · Corpus Université Laval (Université Laval)
- Authors
- Park, S.-Y., Cho, Y.-R., Kim, H.-J., Hong, E.-G., Higashimori, T., Lee, S. J., Goldberg, I. J., Shulman, G. I., Najjar, S. M., & Kim, J. K.
- Affiliations
- Yale University (US)
- ORCID
- Venue
- American Journal of Physiology-Endocrinology and Metabolism
- Publisher
- American Physiological Society
- Published
- 2006-09
- Volume
- 291
- Issue
- 3
- Pages
- E517-E524
- ISSN
- 0193-1849 (ISSN-L)
- 1522-1555
- OpenAlex
- W1976197029
- Cited by
- 51
- References
- 45
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 1 · 2021: 1 · 2020: 1 · 2019: 1 · 2017: 3 · 2016: 3 · 2015: 4 · 2014: 3 · 2013: 2 · 2012: 6
- FWCI
- 1.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Physiology-Endocrinology and Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Yale University
- National Institutes of Health (5r21dk057497-02)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK54254, U24DK59635, R01DK054254, R01DK080756, DK57497, R01DK040936, U24DK059635)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- CEACAM1, impaired glucose tolerance, insulin resistance, hyperinsulinemia, hepatic insulin clearance, dominant negative mutation, visceral obesity, fatty acid synthase, hepatic lipid metabolism, triglycerides, long-chain acyl-CoA, skeletal muscle glucose uptake, adipose tissue glucose uptake, intramuscular fat, 1H NMR, hyperinsulinemic-euglycemic clamp, glucose homeostasis
- MeSH terms
- Acyl Coenzyme A, Animals, Blood Glucose, Carcinoembryonic Antigen, Disease Models, Animal, Glucose, Glycogen, Hyperinsulinism, Insulin, Insulin Resistance, Lipoprotein Lipase, Liver, Triglycerides, Glucose Clamp Technique, Glucose Intolerance, Mice, Knockout, Muscle, Skeletal, Glucose-6-Phosphate, Fatty Acid Transport Proteins, Mice, Fatty Acid Synthases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review